MariMed (OTCMKTS:MRMD) vs. Hero Technologies (OTCMKTS:HENC) Financial Comparison

MariMed (OTCMKTS:MRMDGet Rating) and Hero Technologies (OTCMKTS:HENCGet Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, dividends, valuation and institutional ownership.

Profitability

This table compares MariMed and Hero Technologies’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
MariMed 1.79% 5.18% 1.72%
Hero Technologies N/A N/A -457.02%

Risk and Volatility

MariMed has a beta of 3.4, suggesting that its share price is 240% more volatile than the S&P 500. Comparatively, Hero Technologies has a beta of 0.08, suggesting that its share price is 92% less volatile than the S&P 500.

Institutional and Insider Ownership

0.3% of MariMed shares are owned by institutional investors. Comparatively, 0.0% of Hero Technologies shares are owned by institutional investors. 23.3% of MariMed shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Analyst Ratings

This is a breakdown of recent ratings and price targets for MariMed and Hero Technologies, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MariMed 0 0 3 0 3.00
Hero Technologies 0 0 0 0 N/A

MariMed presently has a consensus price target of $0.85, suggesting a potential upside of 62.06%. Given MariMed’s higher possible upside, equities research analysts clearly believe MariMed is more favorable than Hero Technologies.

Valuation & Earnings

This table compares MariMed and Hero Technologies’ gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
MariMed $121.46 million 1.46 $7.22 million N/A N/A
Hero Technologies N/A N/A -$3.42 million N/A N/A

MariMed has higher revenue and earnings than Hero Technologies.

Summary

MariMed beats Hero Technologies on 10 of the 10 factors compared between the two stocks.

About MariMed

(Get Rating)

MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company offers cannabis genetics produce flowers and concentrates under the Nature's Heritage brand; cannabis-infused products in the form of chewable tablets and powder drink mixes under the brand Kalm Fusion; natural fruit chews under the Betty's Eddies brand; brownies, cookies, and other social sweets under the Bubby's Baked brand; and cannabidiol formulations under the Florance brand. It also licenses its brands and product formulations, as well as leases cannabis facilities. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.

About Hero Technologies

(Get Rating)

Hero Technologies Inc. operates as an early-stage cannabis company. It focuses on the provision of BlackBox, an aeroponic cannabis cultivation system that provides optimal growing conditions to enhance photosynthesis and the cultivation of large flowering plants and create increased harvest efficiencies. The company also intends to offer cannabis genetic engineering farmland for medical and recreational cannabis cultivation, production, distribution, packaging, and retail operations, as well as for dispensaries. The company was incorporated in 2004 and is headquartered in Dover, Delaware.

Receive News & Ratings for MariMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MariMed and related companies with MarketBeat.com's FREE daily email newsletter.